Treating Gliomas Via Preoperative nTMS and Tractography Treating Gliomas Via Preoperative nTMS and Tractography
The authors present a novel multimodal approach to awake surgery for language-eloquent gliomas using preoperative nTMS and nTMS-based diffusion tensor imaging fiber tracking.Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 13, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Polio-Rhinovirus Promising for Malignant Glioma Patients
THURSDAY, July 12, 2018 -- Intratumoral infusion of recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO) can be delivered safely and is tied to higher survival rates than those of historical controls, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2018 Category: Pharmaceuticals Source Type: news

Scientists create nano-size packets of genetic code aimed at brain cancer 'seed' cells
(Johns Hopkins Medicine) In a 'proof of concept' study, scientists at Johns Hopkins Medicine say they have successfully delivered nano-size packets of genetic code called microRNAs to treat human brain tumors implanted in mice. The contents of the super-small containers were designed to target cancer stem cells, a kind of cellular 'seed' that produces countless progeny and is a relentless barrier to ridding the brain of malignant cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2018 Category: International Medicine & Public Health Source Type: news

IsoRay inks $8m private placement deal
IsoRay (NYSE:ISR) has inked a private placement deal worth approximately $8.3 million, according to an SEC filing posted this week. Through the deal, Richland, Wash.-based IsoRay is floating 11 million shares of common stock at 75¢ per share with several institutional and accredited investors, according to the filing. The company said it will also offer unregistered warrants to purchase a number of shares equal to 50% of the investors shares at an exercise price of 75¢, exercisable six months after issuance out to 5.5 years, according to an SEC filing. A total of 5.5 million shares will be offered through th...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat IsoRay Source Type: news

Doctors trying to solve family's stunning medical mystery
Two California siblings, four and six years old, are battling the same kind of brain tumor (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 11, 2018 Category: Consumer Health News Source Type: news

Siblings diagnosed with same cancer within weeks of each other
Doctors in California are trying to solve a family's stunning medical mystery. Two young siblings, four and six years old, were diagnosed with the same kind of brain tumor within two weeks of each other. Now, their parents are speaking out in hopes of raising awareness and encouraging new research. Jamie Yuccas reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 11, 2018 Category: Consumer Health News Source Type: news

Health chiefs back brave Tessa Jowell ’s last wish for ‘gold standard’ cancer test
One of the final requests of the late Dame Tessa Jowell is to be honoured in new official guidance on brain tumour care. (Source: the Mail online | Health)
Source: the Mail online | Health - July 11, 2018 Category: Consumer Health News Source Type: news

More people to be given dye to highlight brain tumours to surgeons say NICE
Hundreds of patients a year set to benefit from roll out of dye to all of England ’s neurosurgical units. (Source: NHS Networks)
Source: NHS Networks - July 11, 2018 Category: UK Health Source Type: news

Mom explains why she shared photo of her daughter's final moments
Casey Daggett, of Fairport, New York, is opening up about her decision to share a photo of the final moments of her daughter, Zoey, before she passed away from a rare, terminal brain tumor. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2018 Category: Consumer Health News Source Type: news

IsoRay wins FDA nod for GammaTile brain tumor treatment
IsoRay (NYSE:ISR) said today it won FDA 510(k) clearance for its GammaTile brachytherapy technology designed for treating recurrent brain tumors. The Richland, Wash.-based company’s GammaTile is a radiation system using Cesium-131 radiation seeds embedded in a collagen ’tile’ which is designed to be placed in surgical margins at the time of surgery. IsoRay said it had previously inked a collaborative development and ten-year supply agreement for the newly cleared GammaTile with GT Medical Technology, which the company said will be available in the US “in the near future.” “We are ve...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Neurological Oncology Regulatory/Compliance IsoRay Source Type: news

Penn study finds mutation driving deadlier brain tumors and potential therapy to stop it
(University of Pennsylvania School of Medicine) A poorly understood mutation in the brain cancer glioblastoma (GBM) is now being implicated for the first time as the driver of rare but deadlier cases of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 9, 2018 Category: Cancer & Oncology Source Type: news

Doctors hope new AI technology will better identify brain tumors
Researchers aim to use artificial intelligence technology to perform "virtual biopsies" to help identify a tumor without surgery. CBS Boston's Dr. Mallika Marshall reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 5, 2018 Category: Consumer Health News Source Type: news

"Virtual biopsies" may help reveal brain tumors' secrets
Doctors hope new technology using artificial intelligence will better identify brain tumors (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 5, 2018 Category: Consumer Health News Source Type: news

Viral immunotherapy to treat brain tumors in children shows promise
A viral immunotherapy using a herpes virus to treat brain tumors has been shown to be safe and well-tolerated in a pediatric study from UAB and Children ’s of Alabama.  The findings managed to show preliminary evidence of effectiveness in killing malignant tumor cells.  The funding to develop the therapy has been provided by the NIH/NCI, Department of Defense, St. Baldrick’s Foundation, Rally Foundation for Childhood Cancer Research, Cannonb all Kid’s Foundation, Hyundai Hope on Wheels, Vs.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 5, 2018 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Viral immunotherapy to treat brain tumors in children shows promise
A viral immunotherapy using a herpes virus to treat brain tumors has been shown to be safe and well-tolerated in a pediatric study from UAB and Children ’s of Alabama.  The findings managed to show preliminary evidence of effectiveness in killing malignant tumor cells.  The funding to develop the therapy has been provided by the NIH/NCI, Department of Defense, St. Baldrick’s Foundation, Rally Foundation for Childhood Cancer Research, Cannonb all Kid’s Foundation, Hyundai Hope on Wheels, Vs.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 5, 2018 Category: Biotechnology Authors: Tyler Patchen Source Type: news

MGMT promoter methylation associated with improved survival for patients with WHO Grade II Gliomas
(NRG Oncology) Further exploration into the endpoints of the NRGOncology/RTOG 0424 trial resulted in the discovery that MGMT promoter methylation is an independent prognostic biomarker of high-risk, low-grade glioma treated with temozolomide and radiation. This is the first study of its kind to validate the prognostic significance of MGMT promoter methylation in this patient population and treatment regimen. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: news

Artificial Intelligence, ‘ Virtual Biopsies ’ May Be The Future Of Understanding Brain Tumors
BOSTON (CBS) — Artificial intelligence is being used increasingly in medicine to make services more efficient and improve patient care. Now, local researchers plan to use the technology to perform “virtual biopsies” of brain tumors. Steven Hibbert considered himself a healthy guy. Then suddenly his life changed on a dime. “I was just kind of sitting there, reading the paper, and went into a seizure,” said Hibbert. The 55-year-old Cape Cod resident was rushed to the hospital and got the news no one wants to hear. He had a brain tumor. “Life changing as my wife always says,” exp...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 4, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Artificial Intelligence brain tumor Cape Cod Dr. Mallika Marshall Health News Source Type: news

A first look at interstitial fluid flow in the brain
(American Institute of Physics) Past research has shown a link between interstitial fluid flow and an increased invasion rate of glioblastoma cells, and biomedical researchers and electrical engineers recently developed a new method to measure and reconstruct interstitial fluid flow velocities in the brain. This method gives a first look at interstitial fluid flow dynamics in glioma models, and the technique can readily translate to clinical models already using contrast-enhanced MRI. The team describes their method in APL Bioengineering. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2018 Category: International Medicine & Public Health Source Type: news

Teamwork between cells fuels aggressive childhood brain tumor
(Cancer Research UK) Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2018 Category: Cancer & Oncology Source Type: news

MGMT Methylation a Survival Biomarker in High-Risk Low-Grade Gliomas?
These are the first data to highlight the prognostic value ofMGMTmethylation beyond theIDH1/2 mutation status test currently used to help predict glioma patient survival outcomes. (Source: CancerNetwork)
Source: CancerNetwork - June 29, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Delivery Device Sends'Chemosurgery' to Brainstem Tumor Delivery Device Sends'Chemosurgery' to Brainstem Tumor
Convection-enhanced drug infusion achieves high local concentrations with little or no systemic exposure in children with inoperable pontine glioma.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 29, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Living With Cancer: Understanding glioma
Glioma? Glioma is one of the most common types of primary brain tumors and can occur in the brain and spinal cord. Gliomas begin in the glial cells ? the gluey supportive cells that surround nerve cells and help them function. A glioma can affect your brain function and be life-threatening, depending on its location [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 29, 2018 Category: Databases & Libraries Source Type: news

Men and women have different genetic risk factors for developing brain cancer
(Case Western Reserve University) A team from Case Western Reserve University School of Medicine, together with an international consortium of researchers, have discovered that men and women have different genetic risk factors for developing glioma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2018 Category: Cancer & Oncology Source Type: news

Genetic biomarker linked to improved survival for patients with certain brain tumors
(MediaSource) It wasn't the first wedding anniversary present that Lori Mines was hoping for. After seeking treatment for a debilitating migraine, Lori was diagnosed with advanced stage brain cancer. The prognosis for the disease is usually poor, but researchers are giving some patients with malignant brain tumors new hope for a longer life through research to help predict tumor aggressiveness and survival based on the unique characteristics of their tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2018 Category: Cancer & Oncology Source Type: news

Poliovirus therapy for recurrent glioblastoma has three year survival rate of 21 percent
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial. Comparatively, just 4 percent of patients at Duke with the same type of recurring brain tumors were alive at three years when undergoing the previously available standard treatment. (Source: World Pharma News)
Source: World Pharma News - June 27, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Enemy turned ally: Poliovirus used to fight brain tumours
Encouraging to see 'extraordinary responders' among 61 people whose tumours had recurred after initial treatments, independent expert says. (Source: CBC | Health)
Source: CBC | Health - June 26, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Poliovirus is used to help fight deadly brain tumors
One of the world's most dreaded viruses has been turned into a treatment to fight deadly brain tumors, doctors report (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 26, 2018 Category: Consumer Health News Source Type: news

Polio Virus May Help Fight Brain Tumors
An ancient scourge -- the polio virus -- may be an unexpected friend to people battling one of the deadliest brain cancers, new research shows. (Source: WebMD Health)
Source: WebMD Health - June 26, 2018 Category: Consumer Health News Source Type: news

Brain Tumor Patients May Have Unlikely Ally: the Polio Virus
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 26, 2018 Category: Cancer & Oncology Tags: Oncology, News, Source Type: news

7T MRI may release mercury from amalgam dental fillings
MR imaging at 7-tesla magnet strength may release toxic mercury from amalgam...Read more on AuntMinnie.comRelated Reading: Glucose-MRI technique at 7T aids tumor evaluation Minimal side effects from 7T MRI subside in minutes Teeth: The feature radiologists need to know more about Study links frequent dental x-rays with brain tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2018 Category: Radiology Source Type: news

Use of polio virus in treating brain cancer shows "dramatic advance"
Doctors using the polio virus to treat aggressive brain tumors called glioblastomas report promising results. Sen. John McCain has this type of cancer, and so did Sen. Ted Kennedy. Of 61 patients treated in one study, 21 percent were still alive at the three-year mark. That's compared with just four percent of patients who received standard cancer treatment. Dr. David Agus, director of USC Norris Westside Cancer Center, joins "CBS This Morning" to discuss the treatment. He also weighs in on a study that showed flight attendants had a higher cancer prevalence than the general population. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 26, 2018 Category: Consumer Health News Source Type: news

Polio could be used to fight brain tumors
Survival was better than expected for patients in a small study at Duke University who were given genetically modified poliovirus, which helped their bodies attack the cancer, doctors report. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Enemy turned ally: Poliovirus is used to fight brain tumors
Doctors have genetically modified poliovirus to make an immune system therapy to fight deadly brain tumors (Source: ABC News: Health)
Source: ABC News: Health - June 26, 2018 Category: Consumer Health News Tags: Health Source Type: news

Polio Virus Could Help Treat Brain Cancer. Here ’s How
The idea that viruses may be co-opted to do good rather than harm isn’t entirely new; researchers have been attempting to harness the power of viruses and bacteria for more than a century. Vaccines are the shining example of using bad bugs to do good in priming the immune system to fight disease. But disease-causing viruses aren’t always easy to corral, and attempts to use them to activate the immune system against things other than fellow bacteria and viruses — including cancer, for example — have not been so successful. There is only one approved virus-based treatment for cancer, which uses herpes...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Brain Tumor Patients May Have Unlikely Ally: the Polio Virus
TUESDAY, June 26, 2018 -- An ancient scourge -- the polio virus -- may be an unexpected friend to people battling one of the deadliest brain cancers, new research shows. The new therapy uses a tweaked, harmless form of the polio virus to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 26, 2018 Category: General Medicine Source Type: news

Brain Tumor Patients May Have Unlikely Ally: the Polio Virus
Title: Brain Tumor Patients May Have Unlikely Ally: the Polio VirusCategory: Health NewsCreated: 6/26/2018 12:00:00 AMLast Editorial Review: 6/26/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 26, 2018 Category: Cancer & Oncology Source Type: news

Experimental drug combined with radiation kills brain tumors in pre-clinical studies
(Virginia Commonwealth University) A new study led by scientists at VCU Massey Cancer Center has shown that an experimental drug known as AZ32 selectively sensitizes brain tumors to radiation and significantly extends the survival of mouse models with human glioblastoma multiforme (GBM), the most common and deadly form of brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Brain Tumor Patients May Have Unlikely Ally: the Polio Virus
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Novel nuclear medicine approach shows promise for treating wide array of cancerous tumors
(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children. The research was presented today at the SNMMI 2018 Annual Meeting, June 23-26 in Philadelphia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Midwife reveals how her hands and feet wouldn ’t stop growing – because of a brain tumour
Chloe Powell, a 26-year-old midwife from Bristol, developed acromegaly because of a benign brain tumour, which made her hands and feet grow uncontrollably, and her facial features swell up. (Source: the Mail online | Health)
Source: the Mail online | Health - June 22, 2018 Category: Consumer Health News Source Type: news

Girl, 3, with an inoperable brain tumour may now survive
Edie Molyneux, from Tranmere, Wirral, was expected to die young because of the rare mass on her brain, known as a diffuse intrinsic pontine glioma (DIPG). (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2018 Category: Consumer Health News Source Type: news

Mother-of-two, 30, was diagnosed with a golf-ball sized brain tumour after crashing her car
Lauren Neville, 30, from Burnley, Lancashire, whose 10 daily seizures were initially dismissed as depression, discovered she had a 6cm  tumour after having a fit behind the wheel last January. (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2018 Category: Consumer Health News Source Type: news

UNF, Mayo experiment with rare 3-D microscope
Researchers at the University of North Florida's Materials Science and Engineering Research Facility watched as dozens of dots scattered across their computer screen. Some dots balled up, others exploded. The dots were cancerous cells from a brain tumor recently removed by a Mayo Clinic neurosurgeon. The visual was made possible by an advanced microscope, the only one of its kind in North America, which can zoom into individual cells without staining and killing cells, as microscopes typically do. "It… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 18, 2018 Category: American Health Authors: Will Robinson Source Type: news

Father-of-three battling brain tumor has defied his life expectancy with experimental shot
Jeff Tabor, 53, has glioblastoma, which has an average life expectancy of 13-15 months. But with an experimental immunotherapy shot, he has lived 18 months and feels 'better every day.' (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2018 Category: Consumer Health News Source Type: news

Father-of-three battling brain tumor outlives prognosis with new shot
Jeff Tabor, 53, has glioblastoma, which has an average life expectancy of 13-15 months. But with an experimental immunotherapy shot, he has lived 18 months and feels 'better every day.' (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2018 Category: Consumer Health News Source Type: news

UC Davis Health names Harsh, Meg Whitman's husband, as new neurology chair
Dr. Griffith R. Harsh IV, vice chair of Stanford University's Brain Tumor Center, has been selected to lead UC Davis Health's neurology department. Harsh, who has been with Stanford Health for 20 years, begins his new role in Sacramento on July 1. Harsh is married to former eBay and Hewlett Packard Enterprise CEO and California gubernatorial candidate Meg Whitman. The couple recently purchased a condo at the Kimpton Sawyer Hotel in downtown Sacramento, and enjoyed their first Kings game, Harsh… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 13, 2018 Category: Pharmaceuticals Authors: Kayla Webster Source Type: news

Mercy Health launches brain tumor center
Mercy Health is partnering with two of the region ’s largest independent physician groups to launch the Brain Tumor Center at Jewish Hospital in Kenwood. The collaboration aligns the Cincinnati-based Mercy Heath hospital system with Norwood-based Mayfield Brain& Spine and Linwood-based cancer-care specialist OHC Inc. The Brain Tumor Center at 4777 E. Galbraith Road includes 22 physicians who specialize in neurosurgery, otolaryngology (ear, nose and throat), radiation oncology, medical oncology,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 12, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Dad shares photo of son comforting four-year-old sister dying from rare terminal brain tumor
Matt Sooter, of Rodgers, Arkansas, shared a photo on Facebook of his son, Jackson, six, comforting his four-year-old sister, Addy, before she passed away from cancer on June 3. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2018 Category: Consumer Health News Source Type: news

Reviving the protector: new tactic against medulloblastoma
(Emory Health Sciences) Scientists have a new tactic with potential for fighting medulloblastoma, the most common and most aggressive form of brain tumor in children. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2018 Category: Cancer & Oncology Source Type: news

New method helps make orthotopic brain-tumor imaging clearer and faster
(Chinese Academy of Sciences Headquarters) A research team led by Prof. ZHENG Hairong from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences, in collaboration with Prof. LIU Bin from the University of Singapore, reported the first NIR-II fluorescent molecule with aggregation-induced-emission (AIE) characteristics for dual fluorescence and photoacoustic imaging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2018 Category: International Medicine & Public Health Source Type: news